Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Modeling the impact of RV144-like vaccines on HIV transmission.

Hankins CA, Glasser JW, Chen RT.

Vaccine. 2011 Aug 18;29(36):6069-71. doi: 10.1016/j.vaccine.2011.07.001. Epub 2011 Jul 14. No abstract available.

2.

HIV vaccine development.

Singh M, Jeang KT, Smith SM.

Front Biosci. 2005 Sep 1;10:2064-81. Review.

PMID:
15970479
3.

The HIV vaccine pipeline, from preclinical to phase III.

Schultz AM, Bradac JA.

AIDS. 2001;15 Suppl 5:S147-58. Review. No abstract available.

PMID:
11816163
4.

Evaluating therapeutic vaccines in patients infected with HIV.

Autran B, Costagliola D, Murphy R, Katlama C.

Expert Rev Vaccines. 2004 Aug;3(4 Suppl):S169-77. Review.

PMID:
15285715
5.
6.

Prospects for a globally effective HIV-1 vaccine.

Excler JL, Robb ML, Kim JH.

Vaccine. 2015 Nov 27;33 Suppl 4:D4-12. doi: 10.1016/j.vaccine.2015.03.059. Epub 2015 Jun 20. Review.

PMID:
26100921
7.

Prospects for a Globally Effective HIV-1 Vaccine.

Excler JL, Robb ML, Kim JH.

Am J Prev Med. 2015 Dec;49(6 Suppl 4):S307-18. doi: 10.1016/j.amepre.2015.09.004. Review.

PMID:
26590431
8.

Mucosal Vaccination for Prevention of HIV Infection and AIDS.

Aldovini A.

Curr HIV Res. 2016;14(3):247-59. Review.

PMID:
26957199
9.

AIDS vaccine 2001: looking to the future.

Mitsuyasu RT.

Afr Health Sci. 2001 Dec;1(2):99-105. Review. No abstract available.

10.

Approaches to preventative and therapeutic HIV vaccines.

Gray GE, Laher F, Lazarus E, Ensoli B, Corey L.

Curr Opin Virol. 2016 Apr;17:104-9. doi: 10.1016/j.coviro.2016.02.010. Epub 2016 Mar 15. Review.

11.

No acquisition: a new ambition for HIV vaccine development?

Lakhashe SK, Silvestri G, Ruprecht RM.

Curr Opin Virol. 2011 Oct;1(4):246-53. doi: 10.1016/j.coviro.2011.07.005. Review.

12.

Vaccine applications of flow cytometry.

De Rosa SC.

Methods. 2012 Jul;57(3):383-91. doi: 10.1016/j.ymeth.2012.01.001. Epub 2012 Jan 10. Review.

13.

Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review.

Girard MP, Osmanov S, Assossou OM, Kieny MP.

Vaccine. 2011 Aug 26;29(37):6191-218. doi: 10.1016/j.vaccine.2011.06.085. Epub 2011 Jun 28. Review.

PMID:
21718747
14.

How do viral and host factors modulate the sexual transmission of HIV? Can transmission be blocked?

Gupta K, Klasse PJ.

PLoS Med. 2006 Feb;3(2):e79. Epub 2006 Feb 28. Review. No abstract available.

15.

Strategies for eliciting HIV-1 inhibitory antibodies.

Tomaras GD, Haynes BF.

Curr Opin HIV AIDS. 2010 Sep;5(5):421-7. doi: 10.1097/COH.0b013e32833d2d45. Review.

16.

Novel directions in HIV-1 vaccines revealed from clinical trials.

Excler JL, Tomaras GD, Russell ND.

Curr Opin HIV AIDS. 2013 Sep;8(5):421-31. doi: 10.1097/COH.0b013e3283632c26. Review.

17.

Prime-boost immunization strategies against HIV.

Barnett SW, Klinger JM, Doe B, Walker CM, Hansen L, Duli├Ęge AM, Sinangil FM.

AIDS Res Hum Retroviruses. 1998 Oct;14 Suppl 3:S299-309. Review. No abstract available.

PMID:
9814958
18.

Post-step modifications for research on HIV vaccines.

Corey L, McElrath MJ, Kublin JG.

AIDS. 2009 Jan 2;23(1):3-8. doi: 10.1097/QAD.0b013e32830e6d6d. Review. No abstract available.

Supplemental Content

Support Center